Resources
Healthcare IT Today March 8, 2024 Read the full article >> Joseph Zabinski, Ph.D. VP, Head of Commercial Strategy & AI at OM1 Dr. Carl Marci, Chief Clinical Officer, Chief Psychiatrist and Managing Director of Mental Health and Neuroscience at OM1 The industry is seeing an uptick of ambient voice technologies used to help increase the efficiency,[…]
Pharma’s Almanac March 8, 2024 Read the full article >> Richard Gliklich, M.D., Chief Executive Officer, OM1, Inc. One of the most promising paths being applied to accelerate product development and commercialization comes in the form of real-world data/evidence (RWD/RWE) and applied AI. In clinical development, we are using de-identified RWD to identify clinical sites with eligible[…]
NeurologyLive March 7, 2024 Isabella Ciccone, MPH Read the full article >> Presented at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum, held February 29 to March 2, in West Palm Beach, Florida, a machine learning model applied to predict disability in a real-world data (RWD) source increased the number of[…]
Healio March 1, 2023 Robert Herpen Read the full article >> Key takeaways: A machine-learning model produced 46,644 estimated scores on a disability scale from 3,404 scores. Application could increase study volunteers and create potential for a tool to tailor treatment plans. WEST PALM BEACH, Fla. — Application of a machine learning model to databases[…]
Dermatology Times February 29, 2024 Kaitlyn Bader, Senior Editor Joseph Zabinski, PhD, MEM Read the full article >> This Rare Disease Day, Joseph Zabinski, PhD, MEM, of OM1, discusses the role of artificial intelligence in helping to detect rare dermatologic diseases. Rare Disease Day has been observed globally every year on the last day of[…]
